Abstract
A number of common functtonally significant genetic polymorphisms in genes encoding certain cytochromes P450 have been described and characterized (for review, see refs. 1 and 2). Individuals may lack certain enzyme activities or have higher or lower than normal activities owing to the presence of certain variant alleles. These individuals may be at altered risk of developing adverse drug reactions or drseases associated wtth xenobiotrc exposure, including cancer. Variant alleles can be detected by the direct approach of genotyping where the individual’s DNA is directly examined usually by an assay involving use of the polymerase chain reactton (PCR), or by phenotypmg, where the individual’s pattern of metabolites produced from a probe drug is examined. This chapter describes the detection of common polymorphisms in cytochrome P450 genes using both genotyping and phenotypmg approaches. Genotyping is now generally preferred to phenotyping because it is more convenient, requiring only a single blood sample, which can be taken at any time. It can also be used on stored blood or other tissue samples. Phenotyping, however, is useful when investigating drug interactrons in viva and in situations where the molecular basis of a polymorphism is unclear. In the sections of this chapter covering genotyping, we describe general methods for PCR and analysts of PCR products that have been used to genotype for pharmacogenetic polymorphisms, together with the specific conditions used to detect a range of known polymorphisms in cytochrome P450 genes. Methods for phenotypic detection of polymorphisms in CYP2D6 and CYP2A6 are also described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Daly, A. K (1995) Molecular basis of polymorphic drug metabolism J Mol Med 73, 539–553.
Evans, D A P (1993) Genetic Factors in Drug Therapy Clinical and Molecular Pharmacogenetics Cambridge Universtty Press, Cambridge, UK.
Daly, A K, Brockmoller, J, Broly, F, Eichelbaum, M, Evans, W. E., Gonzalez, F. J., Huang, J.-D, Idle, J. R, Ingelman-Sundberg, M, Ishizaki, T, Jacqz-Aigram, E., Meyer, U. A., Nebert, D W, Steen, V. M., Wolf, C R., and Zanger, U. M. (1996) Nomenclature for human CYP2D6 alleles Pharmacogenetics 6, 193–201.
Fernandez-Salguero, P, Hoffman, S. M. G, Cholerton, S., Mohrenweiser, H, Raunio, H., Pelkonen, O., Huang, J., Evans, W. E., Idle, J R, and Gonzalez, F. J. (1995) A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles Am J. Hum Genet 57, 651–660.
Newton, C. R. (1995) PCR Essentzal Data John Wiley, Chichester, UK
Rautio, A., Kraul, A., KoJo, A, Salmela, E, and Pelkonen, O (1992) Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 2, 227–233
Jackson, D. P, Hayden, J. D., and Qutrke, P (1991) Extraction of nucleic acid from fresh and archival material, in PCR, A Practical Approach (McPherson M. J., Quirke P., and Taylor G R., eds.), IRL, Oxford, UK, pp. 29–50
de Morals, S. M. F., Wilkinson, G. R., Blaisdell, J., Nakamura, K., Meyer, U. A, and Goldstein, J A (1994) The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J. Biol Chem 269, 15,419–15,422.
de Morals, S.M F., Wilkinson, G. R., Blaisdell, J, Meyer, U. A., Nakamura, K, and Goldstein, J. A (1994) Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytom metabolism in Japanese. Mel Pharmacol 46, 594–598
Cascorbi, I., Brockmoller, J., and Roots, I. (1996) A C4887A polymorphism in exon 7 of human CYPIAI-population frequency, mutation linkages and impact on lung cancer susceptibility. Cancer Res 56, 4965–4969.
Shields, P. G., Bowman, E D., Harrington, A M, Doan, V. T. and Weston, A. (1993) Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 53, 3486–3492.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc.
About this protocol
Cite this protocol
K. Daly, A., C. Monkman, S., Smart, J., Steward, A., Cholerton, S. (1998). Analysis of Cytochrome P450 Polymorphisms. In: Phillips, I.R., Shephard, E.A. (eds) Cytochrome P450 Protocols. Methods in Molecular Biology™, vol 107. Humana Press. https://doi.org/10.1385/0-89603-519-0:405
Download citation
DOI: https://doi.org/10.1385/0-89603-519-0:405
Publisher Name: Humana Press
Print ISBN: 978-0-89603-519-5
Online ISBN: 978-1-59259-580-8
eBook Packages: Springer Protocols